Lower response to early T-cell-dependent vaccination after neurotrauma or neurosurgery in adults

Anna Ljunghill Hedberg1, Karlis Pauksens1, Elisabeth Ronne-Engström2

  • 1Dept of Medical Sciences, Section of Infectious Diseases, Uppsala University, Sweden.

The Journal of Infection
|January 7, 2015
PubMed

Insights

Early vaccination against Haemophilus influenza type b (Hib) after neurotrauma or neurosurgery may reduce vaccine effectiveness. Further research is needed to determine optimal pneumococcal conjugate vaccine timing in these patients.

Area of Science:

  • Immunology
  • Neuroscience
  • Vaccinology

Background:

  • International guidelines recommend 13-valent pneumococcal conjugate vaccine for meningitis prevention post-neurotrauma with cerebrospinal fluid leak.
  • Optimal antibody response and timing for vaccination remain unestablished.
  • Early vaccination is preferred due to the high risk of meningitis shortly after trauma.

Purpose of the Study:

  • To investigate the antibody response to a T-cell-dependent conjugate vaccine shortly after central nervous system injury.
  • To assess if neurotrauma-induced immunodepression affects vaccine response.
  • To evaluate the antibody response to Haemophilus influenza type b (Hib) conjugate vaccine in neurotrauma and neurosurgery patients.

Main Methods:

  • A Haemophilus influenza type b (Hib) conjugate vaccine was administered to 33 neurotrauma and 23 neurosurgery patients within 10 days of injury/surgery.
  • 29 control patients were vaccinated at least three weeks post-injury/surgery.
  • Serum anti-Hib concentrations were measured pre- and post-vaccination.

Main Results:

  • A higher proportion of non-responders was observed in the early vaccination groups (31% neurotrauma, 25% neurosurgery) compared to controls (10%).
  • Log10 anti-Hib concentrations were lower in neurotrauma (1.52 ± 0.15 μg/ml) and neurosurgery (1.38 ± 0.15 μg/ml) groups compared to controls (1.81 ± 0.12 μg/ml).
  • Four patients with pre-existing target antibody concentrations were excluded from analysis.

Conclusions:

  • Vaccination early after neurotrauma or neurosurgery resulted in a decreased number of responders and lower antibody concentrations.
  • These findings suggest potential immunodepression affecting vaccine response in the early post-injury period.
  • Urgent investigation into pneumococcal conjugate vaccine response in neurotrauma patients is warranted.
Abstract